// App-Quantinova.ai

15424 : Clinical Implications of Dual Antiplatelet Therapy Cessation Within 12 Months of Coronary Stenting in Men and Women: A Pooled Analysis From the Platinum Diversity and Promus Element Plus Post-Approval Studies

Researchers

Presenter

  • Rishi Chandiramani

Principal Investigators

  • Davide Cao

  • Roxana Mehran

  • Moritz Blum

  • Anastasios Roumeliotis

  • Ridhima Goel

  • Samantha Sartori

  • Scott Davis

  • Luis Tami

  • John Wang

  • Islam Othman

  • Osvaldo Gigliotti

  • Kevin Boran

  • Henry Liberman

  • Paul Underwood

  • Dominic Allocco

  • Wayne Batchelor

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved